| It appears the key to you living with Multiple Sclerosis | | | | give yourself a good foundation for good health. You |
| is that you must feel in control of your Multiple | | | | should always talk with your health care provider or |
| Sclerosis. How can you do this you ask? You do this | | | | you Multiple Sclerosis specialist before entering into |
| by keeping track of your symptoms, by going to | | | | any symptom related management program. |
| your appointments with your health care professional, | | | | Remember the message here, stay in control of your |
| not skipping your scheduled magnetic resonance | | | | disease and the process. |
| imaging and by taking your medications that your | | | | Clearly, if your health care provider has prescribed a |
| health care provider has prescribed. All too often | | | | disease modifying drug, it is imperative that you |
| when things appear to be going well, we (meaning | | | | follow your doctor's recommendations, with no |
| you) think some of what you need to be doing to | | | | exceptions. New drugs were introduced about fifteen |
| stay in control is not needed. Not so, do it religiously! | | | | years ago that showed a breakthrough for people |
| Now I know that the exact relationship between | | | | with relapsing Multiple Sclerosis. It appears that these |
| your magnetic resonance imaging and your present | | | | new drugs slow down the process. If you have |
| or future clinical status of you as a patient, including | | | | Multiple Sclerosis and are not familiar with what I just |
| your disease progression is an unknown. But to take | | | | stated, at least go to your health care provider and |
| any chances is clear stupidity, stay in charge of what | | | | go over your treatment options and decide if any of |
| is going on with you. | | | | the new therapy is right for you. Remember as |
| You should follow a well balanced diet and also follow | | | | always, live well to be well. Stay informed! |
| your now properly prescribed exercise program to | | | | |